There are increasing indications of a buyout of Translate bio (US) by Sanofi (France). Both are closely linked through the development of an mRNA Covid vaccine. Last friday (February 26th) CEO Ron Renaud was interviewed by Geoff Porges at the 10th Annual SVB Leerink Global Healthcare Conference. Look at Ron's smile when asked about the standstill agreement with Sanofi. It speaks volumes :) Translate's stock quotes responded promptly. Has the race started?
Category
🗞
News